1
|
Lahm H, Stieglbauer S, Neb I, Doppler S, Schneider S, Dzilic E, Lange R, Krane M, Dreßen M. Generation of three CRISPR/Cas9 edited human induced pluripotent stem cell lines (DHMi005-A-5, DHMi005-A-6 and DHMi005-A-7) carrying a Holt-Oram Syndrome patient-specific TBX5 mutation with known cardiac phenotype and a FLAG-tag after exon 9 of the TBX5 gene. Stem Cell Res 2023; 69:103123. [PMID: 37210946 DOI: 10.1016/j.scr.2023.103123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/16/2023] [Revised: 04/24/2023] [Accepted: 05/11/2023] [Indexed: 05/23/2023] Open
Abstract
TBX5 is a transcription factor (TF) playing essential role during cardiogenesis. It is well known that TF mutations possibly result in non- or additional binding of the DNA due to conformational changes of the protein. We introduced a Holt-Oram Syndrome (HOS) patient-specific TBX5 mutation c.920_C > A heterozygously in a healthy induced pluripotent stell cell (iPSC) line. This TBX5 mutation results in conformational changes of the protein and displayed ventricular septal defects in the patient itself. Additionally we introduced a FLAG-tag on the TBX5 mutation-carrying allele. The resulting heterozygous TBX5-FLAG iPSC lines are a powerful tool to investigate altered TF activity bonding.
Collapse
Affiliation(s)
- H Lahm
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany.
| | - S Stieglbauer
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany; Hochschule München University of Applied Sciences, Munich, Germany
| | - I Neb
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany
| | - S Doppler
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany
| | - S Schneider
- Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany
| | - E Dzilic
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany
| | - R Lange
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany; DZHK (German Center for Cardiovascular Research) - Partner Site Munich Heart Alliance, Munich, Germany
| | - M Krane
- DZHK (German Center for Cardiovascular Research) - Partner Site Munich Heart Alliance, Munich, Germany; Division of Cardiac Surgery, Yale University School of Medicine, New Haven, CT, USA
| | - M Dreßen
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany.
| |
Collapse
|
2
|
Lahm H, Stieglbauer S, Neb I, Doppler SA, Schneider S, Dzilic E, Lange R, Krane M, Dreßen M. Generation of two CRISPR/Cas edited human induced pluripotent stem cell lines (DHMi005-A-3 and DHMi005-A-4) carrying a FLAG-tag after exon 9 of the TBX5 gene. Stem Cell Res 2023; 66:103011. [PMID: 36610218 DOI: 10.1016/j.scr.2022.103011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/13/2022] [Revised: 11/29/2022] [Accepted: 12/25/2022] [Indexed: 12/29/2022] Open
Abstract
Although TBX5 plays a major role during human cardiogenesis and initiates and controls limb development, many of its interactions with genomic DNA and the resulting biological consequences are not well known. Existing anti-TBX5-antibodies work very inefficiently in certain applications such as ChIP-Seq analysis. To circumvent this drawback, we introduced a FLAG-tag sequence into the TBX5 locus at the end of exon 9 prior to the stop codon by CRISPR/Cas9. The expressed TBX5-FLAG fusion protein can effectively be precipitated by anti-FLAG antibodies. Therefore, these gene-edited iPSC lines represent powerful cellular in vitro tools to unravel TBX5:DNA interactions in detail.
Collapse
Affiliation(s)
- H Lahm
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany.
| | - S Stieglbauer
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany; Hochschule München University of Applied Sciences, Munich, Germany
| | - I Neb
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany
| | - S A Doppler
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany
| | - S Schneider
- Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany
| | - E Dzilic
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany
| | - R Lange
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany; DZHK (German Center for Cardiovascular Research) - partner site Munich Heart Alliance, Munich, Germany
| | - M Krane
- DZHK (German Center for Cardiovascular Research) - partner site Munich Heart Alliance, Munich, Germany; Division of Cardiac Surgery, Yale University School of Medicine, New Haven, CT, USA
| | - M Dreßen
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany.
| |
Collapse
|
3
|
Dreßen M, Luzius T, Lahm H, Neb I, Doppler SA, Schneider S, Dzilic E, Lange R, Krane M. Establishment of an induced pluripotent stem cell line DHMi005-A from a healthy male proband. Stem Cell Res 2022; 59:102662. [PMID: 35033855 DOI: 10.1016/j.scr.2022.102662] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Accepted: 01/06/2022] [Indexed: 11/18/2022] Open
Abstract
We generated an induced pluripotent stem cell (iPSC) line from a healthy male 29-year-old proband. Adipose fibroblasts (AFs) were reprogrammed using Sendai virus. Generated iPSCs showed typical stem cell morphology. From passage 9 on, iPSCs were free of virus. Pluripotency in the iPSCs was verified and spontaneous differentiation showed expression of all three germ layers. Karyotyping indicated no anomalies for the generated iPSCs. Many patient-specific iPSCs are generated from subcutaneous fat fibroblasts obtained during surgical procedure. The described control iPSC line was generated equally and therefore serves as an ideal control for adipose-fibroblast-based patient-specific iPSC lines in disease modeling.
Collapse
Affiliation(s)
- M Dreßen
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany.
| | - T Luzius
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany
| | - H Lahm
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany
| | - I Neb
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany
| | - S A Doppler
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany
| | - S Schneider
- Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany
| | - E Dzilic
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany
| | - R Lange
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany; DZHK (German Center for Cardiovascular Research) - Partner Site Munich Heart Alliance, Munich, Germany
| | - M Krane
- DZHK (German Center for Cardiovascular Research) - Partner Site Munich Heart Alliance, Munich, Germany; Division of Cardiac Surgery, Yale University School of Medicine, New Haven, CT, USA
| |
Collapse
|
4
|
Heinrich P, Ottelé L, Dzilic E, Doppler S, Sager H, Dreßen M, Lahm H, Lange R, Krane M. Development of a Triple Genome-Edited Hypoimmunogenic Human-Induced Pluripotent Stem Cell Line which Allows In vivo Tracking of Cardiomyocyte Maturation upon Transplantation. Thorac Cardiovasc Surg 2022. [DOI: 10.1055/s-0042-1742873] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- P. Heinrich
- Technical University of Munich, School of Medicine and Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, München, Deutschland
| | - L. Ottelé
- Technical University of Munich, School of Medicine and Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, München, Deutschland
| | - E. Dzilic
- Technical University of Munich, School of Medicine and Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, München, Deutschland
| | - S. Doppler
- Technical University of Munich, School of Medicine and Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, München, Deutschland
| | - H. Sager
- Technical University of Munich, School of Medicine and Health, Department of Cardiology, German Heart Center Munich, Germany, München, Deutschland
| | - M. Dreßen
- Technical University of Munich, School of Medicine and Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, München, Deutschland
| | - H. Lahm
- Technical University of Munich, School of Medicine and Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, München, Deutschland
| | - R. Lange
- Technical University of Munich, School of Medicine and Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, München, Deutschland
| | - M. Krane
- Division of Cardiac Surgery, Yale University School of Medicine, New Haven, United States
| |
Collapse
|
5
|
Dreßen M, Lahm H, Neb I, Luzius T, Doppler SA, Schneider S, Dzilic E, Lange R, Krane M. Establishment of a patient-specific induced pluripotent stem cell line DHMi004-A from a male Holt-Oram syndrome patient with verified TBX5 mutation. Stem Cell Res 2021; 58:102617. [PMID: 34894535 DOI: 10.1016/j.scr.2021.102617] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/20/2021] [Revised: 12/01/2021] [Accepted: 12/05/2021] [Indexed: 11/27/2022] Open
Abstract
The Holt-Oram syndrome (HOS) is a rare autosomal dominant disorder, mostly based on mutations in the TBX5 gene. Patients show malformation of at least one upper limb along with congenital heart defects. The established induced pluripotent stem cell (iPSC) line was generated from a patient displaying pronounced and typical features of HOS and carrying a single-nucleotide change c.920_C>A leading to an amino acid change from proline to threonine at amino acid position 85, which appeared de novo. Adipose fibroblasts from the patient were reprogrammed using Sendai virus. Pluripotency of the iPSCs was fully demonstrated.
Collapse
Affiliation(s)
- M Dreßen
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany.
| | - H Lahm
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany
| | - I Neb
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany
| | - T Luzius
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany
| | - S A Doppler
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany
| | - S Schneider
- Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany
| | - E Dzilic
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany
| | - R Lange
- Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany; DZHK (German Center for Cardiovascular Research) - Partner Site Munich Heart Alliance, Munich, Germany
| | - M Krane
- DZHK (German Center for Cardiovascular Research) - Partner Site Munich Heart Alliance, Munich, Germany; Division of Cardiac Surgery, Yale University School of Medicine, New Haven, CT, USA
| |
Collapse
|
6
|
Querdel E, Reinsch M, Castro L, Köse D, Bähr A, Reich S, Geertz B, Ulmer B, Schulze M, Lemoine MD, Krause T, Lemme M, Sani J, Shibamiya A, Stüdemann T, Köhne M, Bibra CV, Hornaschewitz N, Pecha S, Nejahsie Y, Mannhardt I, Christ T, Reichenspurner H, Hansen A, Klymiuk N, Krane M, Kupatt C, Eschenhagen T, Weinberger F. Human Engineered Heart Tissue Patches Remuscularize the Injured Heart in a Dose-Dependent Manner. Circulation 2021; 143:1991-2006. [PMID: 33648345 PMCID: PMC8126500 DOI: 10.1161/circulationaha.120.047904] [Citation(s) in RCA: 45] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Supplemental Digital Content is available in the text. Human engineered heart tissue (EHT) transplantation represents a potential regenerative strategy for patients with heart failure and has been successful in preclinical models. Clinical application requires upscaling, adaptation to good manufacturing practices, and determination of the effective dose.
Collapse
Affiliation(s)
- Eva Querdel
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.)
| | - Marina Reinsch
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.)
| | - Liesa Castro
- Department of Cardiovascular Surgery, University Heart Center (L.C., S.P., H.R.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.).,Now with Department of Cardiology and Intensive Care Medicine, University Hospital Schleswig-Holstein, Campus Lübeck, Germany (L.C.)
| | - Deniz Köse
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.)
| | - Andrea Bähr
- I. Medizinische Klinik & Poliklinik, University Clinic Rechts der Isar (A.B., N.H., N.K., C.K.), Technical University Munich, Germany.,DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance Munich (A.B., N.H., N.K., C.K.).,Center for Innovative Medical Models, LMU Munich, Oberschleissheim, Germany (A.B., N.K.)
| | - Svenja Reich
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany
| | - Birgit Geertz
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany
| | - Bärbel Ulmer
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.)
| | - Mirja Schulze
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.)
| | - Marc D Lemoine
- German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.).,Department of Cardiology-Electrophysiology (M.D.L.), University Heart Center, Hamburg, Germany
| | - Tobias Krause
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.)
| | - Marta Lemme
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.)
| | - Jascha Sani
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.)
| | - Aya Shibamiya
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.)
| | - Tim Stüdemann
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.)
| | - Maria Köhne
- German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.).,Department of Pediatric Cardiac Surgery (M. Köhne), University Heart Center, Hamburg, Germany
| | - Constantin von Bibra
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.)
| | - Nadja Hornaschewitz
- I. Medizinische Klinik & Poliklinik, University Clinic Rechts der Isar (A.B., N.H., N.K., C.K.), Technical University Munich, Germany.,DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance Munich (A.B., N.H., N.K., C.K.)
| | - Simon Pecha
- Department of Cardiovascular Surgery, University Heart Center (L.C., S.P., H.R.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.)
| | - Yusuf Nejahsie
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany
| | - Ingra Mannhardt
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.)
| | - Torsten Christ
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.)
| | - Hermann Reichenspurner
- Department of Cardiovascular Surgery, University Heart Center (L.C., S.P., H.R.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.)
| | - Arne Hansen
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.)
| | - Nikolai Klymiuk
- I. Medizinische Klinik & Poliklinik, University Clinic Rechts der Isar (A.B., N.H., N.K., C.K.), Technical University Munich, Germany.,DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance Munich (A.B., N.H., N.K., C.K.).,Center for Innovative Medical Models, LMU Munich, Oberschleissheim, Germany (A.B., N.K.)
| | - M Krane
- Department of Cardiovascular Surgery, German Heart Centre Munich (M. Krane), Technical University Munich, Germany.,INSURE (Institute for Translational Cardiac Surgery), Cardiovascular Surgery, Munich, Germany (M. Krane)
| | - C Kupatt
- I. Medizinische Klinik & Poliklinik, University Clinic Rechts der Isar (A.B., N.H., N.K., C.K.), Technical University Munich, Germany.,DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance Munich (A.B., N.H., N.K., C.K.)
| | - Thomas Eschenhagen
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.)
| | - Florian Weinberger
- Department of Experimental Pharmacology and Toxicology (E.Q., M.R., D.K., S.R., B.G., B.U., M.S., T.K., M.L., J.S., A.S., T.S., C.v.B., Y.N., I.M., T.C., A.H., T.E., F.W.), University Medical Center, Hamburg-Eppendorf, Germany.,German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck (E.Q., M.R., L.C., D.K., B.U., M.S., M.D.L., T.K., M.L., J.S., A.S., T.S., M. Köhne, C.v.B., S.P., I.M., T.C., H.R., A.H., T.E., F.W.)
| |
Collapse
|
7
|
Krane M, Böhm J, Prinzing A, Lange R. Incidence of Infective Endocarditis after AV: Neocuspidization Using Autologous Pericardium (Ozaki Procedure). Thorac Cardiovasc Surg 2021. [DOI: 10.1055/s-0041-1725754] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
8
|
Dzilic E, Günther T, Bouziani A, Voss B, Krane M, Lange R. Intermediate-Term Results of Tricuspid Valve Repair Using a Three-dimensional Annuloplasty Ring in Functional Tricuspid Regurgitation. Thorac Cardiovasc Surg 2021. [DOI: 10.1055/s-0041-1725685] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
9
|
König C, Lahm H, Dreßen M, Doppler S, Beck N, Holdenrieder S, Doll S, Mann M, Lange R, Krane M. Aggrecan: A New Biomarker for Acute Thoracic Aortic Dissection. Thorac Cardiovasc Surg 2021. [DOI: 10.1055/s-0041-1725841] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
10
|
Lahm H, Wirth F, Dreßen M, Jia M, Puluca N, Cleuziou J, Doppler S, Lange R, Müller-Myhsok B, Krane M. Functional Analysis of Candidate Genes Associated with Congenital Heart Disease during Differentiation of Induced Pluripotent Stem Cells and in the Human Embryonic and Adult Heart at Single-Cell Resolution. Thorac Cardiovasc Surg 2021. [DOI: 10.1055/s-0041-1725667] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
11
|
Lang M, Vitanova K, Voss B, Krane M, Lange R, Günther T. Beyond the 10-Year Horizon: Long-Term Outcome of Mitral Valve Repair Using Chordal Replacement. Thorac Cardiovasc Surg 2021. [DOI: 10.1055/s-0041-1725682] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
12
|
Girdauskas E, Kempfert J, Kuntze T, Holubec T, Krane M, Borger M, Eden M, Bramlage P, Pausch J, Gross TMS, Müller L, Reichenspurner H. Standardized Subannular Repair for Treatment of Secondary Mitral Regurgitation: Initial Results from the Reform-MR Registry. Thorac Cardiovasc Surg 2021. [DOI: 10.1055/s-0041-1725719] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
13
|
Vitanova K, Wirth F, Böhm J, Lange R, Krane M. Surgical Aortic Valve Replacement: Prosthesis Type Is Still a Topic of Discussion. Thorac Cardiovasc Surg 2021. [DOI: 10.1055/s-0041-1725728] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
14
|
Bhadra OD, Vitanova K, Krane M, Tang G, Denti P, Zaid S, Modine T, Kaneko T, Bapat V, Reichenspurner H, Lange R, Conradi L. Outcomes of Mitral Valve Surgery after Edge-to-Edge Transcatheter Mitral Valve Repair: The Cutting-Edge Registry. Thorac Cardiovasc Surg 2021. [DOI: 10.1055/s-0041-1725749] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
15
|
Deutsch O, Deisenhofer I, Koch-Buettner K, Lange R, Krane M. Need for Permanent Pacemaker Implantation following Aortic Valve Replacement with Rapid Deployment Aortic Valve in Combined Procedures. Thorac Cardiovasc Surg 2021. [DOI: 10.1055/s-0041-1725853] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
16
|
Sideris K, Burri M, Prinzing A, Krane M, Guenzinger R, Lange R, Voss B. Long-Term Results of Edge-to-Edge Mitral Valve Repair in Degenerative Mitral Valve Disease: A Single-Center Experience. Thorac Cardiovasc Surg 2020. [DOI: 10.1055/s-0040-1705337] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
17
|
Krane M, Boehm J, Prinzing A, Lange R. Approaching Mid-Term Results for Aortic Valve Reconstruction (Ozaki’s Procedure). Thorac Cardiovasc Surg 2020. [DOI: 10.1055/s-0040-1705368] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
18
|
Dreßen M, Lahm H, Neb I, Abou-Ajram C, Dzilic E, Doppler S, Lange R, Krane M. Generation of Isogenic iPS Cells by CRISPR/Cas Technology to Track TBX5 upon Cardiac Differentiation in a Patient-Specific iPS Model for the Holt–Oram Syndrome. Thorac Cardiovasc Surg 2020. [DOI: 10.1055/s-0040-1705330] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
19
|
Alwan L, Ruge H, Krane M, Lange R, Erlebach M. Incidence of Prosthesis-Patient Mismatch and Short-Term Clinical Outcome after Aortic Valve-in-Valve Implantation Using a Second-Generation Supraannular Self-expanding Valve. Thorac Cardiovasc Surg 2020. [DOI: 10.1055/s-0040-1705412] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
20
|
Lahm H, Jia M, Dreßen M, Gilsbach R, Hein L, Lange R, Meitinger T, Cordell HJ, Müller-Myhsok B, Krane M. Genome-Wide Association Study Identifies Novel Risk Loci in Patients with Transposition of the Great Arteries and Anomalies of the Thoracic Arteries and Veins. Thorac Cardiovasc Surg 2020. [DOI: 10.1055/s-0040-1705331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
21
|
Lahm H, Dreßen M, Beck N, Doppler S, Lange R, Krane M. MYBPHL Plasma Levels Are Increased after Induced Atrial Damage. Thorac Cardiovasc Surg 2020. [DOI: 10.1055/s-0040-1705469] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
22
|
Goppel G, Ruge H, Erlebach M, Deutsch O, Ziegelmueller J, Krane M, Lange R. P913What can we expect after valve-in-valve procedures in failed transcatheter aortic valves? Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz747.0509] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background/Purpose
With the growing use of transcatheter aortic valve replacement (TAVR), we need to determine if repeat TAVR (TAV-in-TAV) is comparable or even superior to surgical aortic valve replacement followed by TAVR (TAV-in-SAV). Although TAV-in-SAV procedures were shown to provide an almost complete sealing of paravalvular leakage at the expense of elevated gradients, data for TAV-in-TAV are lacking. Hence, we compared echocardiographic and clinical outcome in all TAV-in-TAV and TAV-in-SAV procedures in our institution between Oct. 2007 and July 2017.
Methods
130 consecutive valve-in-valve patients out of 2351 TAVR-patients were identified. 24 patients were excluded. Patient data were analysed from our prospectively collected, institutional database. 93% underwent routine out-patient follow-up at 12 months.
Results
75 TAV-in-SAV (75±8 years, male 60%; STS score 5.2±4.0%) and 31 TAV-in-TAV patients (78±8 years, male 65%; STS score 4.6±2.8%) formed the final study population. The type of TAV was similarly distributed in both groups (self-/balloon-expandable valves [%] 57/43 vs. 61/39) with transfemoral being the most frequent access site (68% vs. 87%). The mode of prosthesis failure was mainly stenosis in the TAV-in-SAV group (77%), whereas it was mainly intraoperative paravalvular regurgitation (90%) in the TAV-in-TAV group. 10% TAV-in-TAV patients (78±10 years, 33% male, STS score 5.1±1.5%) underwent redo-TAVR for prosthesis-degeneration after a mean time of 2614±862 days. The TAV-in-TAV group (90% single session vs. 10% staged: mean gradient 10±4 mmHg vs. 15±3 mmHg, p=0.096; aortic valve area 1.62±0.36 cm2 vs. 1.45±0.18 cm2, p=0.240) showed lower gradients and larger aortic valve areas (Table 1). No major intraprocedural complications occurred in either group. 30-day mortality was 0%.
Table 1 75 TAV-in-SAV discharge 31 TAV-in-TAV discharge p-value 69 TAV-in-SAV 12mFU 30 TAV-in-TAV 12mFU p-value AVA (cm2) * 1.18±0.32 1.61±0.35 <0.001† 1.21±0.36 1.63±0.43 <0.001† Peak Gradient (mmHg) 33±14 23±8 <0.001† 31±14 21±8 <0.001† Mean Gradient (mmHg) 19±8 12±5 <0.001† 18±9 11±4 <0.001† AR (0–3)** 0.4±0.5 0.8±0.7 0.003† 0.4±0.5 0.8±0.6 0.001† LV ejection fraction (%) 49±12 49±16 0.970 54±12 50±10 0.081 *AVA = Aortic valve area; **AR = Aortic regurgitation. 0 = none, 1 = mild, 2 = moderate, 3 = severe. †p<0,05 significant.
Conclusion
Indications for TAV-in-TAV differ from those for TAV-in-SAV. TAV-in-TAV results in significantly lower gradients and larger aortic valve areas with no relevant aortic regurgitation. Accordingly, failed TAV valves may be treated with TAV-in-TAV in the future.
Collapse
Affiliation(s)
- G Goppel
- German Heart Center of Munich, Munich, Germany
| | - H Ruge
- German Heart Center of Munich, Munich, Germany
| | - M Erlebach
- German Heart Center of Munich, Munich, Germany
| | - O Deutsch
- German Heart Center of Munich, Munich, Germany
| | | | - M Krane
- German Heart Center of Munich, Munich, Germany
| | - R Lange
- German Heart Center of Munich, Munich, Germany
| |
Collapse
|
23
|
Prinzing A, Boehm J, Lange R, Krane M. Is There a Difference in the Long-Term Results after Repair of Tricuspid and Bicuspid Aortic Valves? Thorac Cardiovasc Surg 2019. [DOI: 10.1055/s-0039-1678962] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- A. Prinzing
- Department of Cardiovascular Surgery, German Heart Center Munich, Munich, Germany
- Insure (Institute of Translational Cardiac Surgery), Department of Cardiovascular Surgery, German Heart Center Munich, Technische Universität München, Munich, Germany
| | - J. Boehm
- Department of Cardiovascular Surgery, German Heart Center Munich, Munich, Germany
- Insure (Institute of Translational Cardiac Surgery), Department of Cardiovascular Surgery, German Heart Center Munich, Technische Universität München, Munich, Germany
| | - R. Lange
- Department of Cardiovascular Surgery, German Heart Center Munich, Munich, Germany
- Insure (Institute of Translational Cardiac Surgery), Department of Cardiovascular Surgery, German Heart Center Munich, Technische Universität München, Munich, Germany
| | - M. Krane
- Department of Cardiovascular Surgery, German Heart Center Munich, Munich, Germany
- Insure (Institute of Translational Cardiac Surgery), Department of Cardiovascular Surgery, German Heart Center Munich, Technische Universität München, Munich, Germany
| |
Collapse
|
24
|
Boehm J, Lange R, Krane M. Underweight or Obesity Paradox: Do BMI Classifications Predict Long-Term Survival after Cardiac Surgery? Thorac Cardiovasc Surg 2019. [DOI: 10.1055/s-0039-1678848] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- J. Boehm
- Technische Universität München, Deutsches Herzzentrum München, Klinik für Herzchirurgie, München, Germany
| | - R. Lange
- Technische Universität München, Deutsches Herzzentrum München, Klinik für Herzchirurgie, München, Germany
| | - M. Krane
- Technische Universität München, Deutsches Herzzentrum München, Klinik für Herzchirurgie, München, Germany
| |
Collapse
|
25
|
Boehm J, Burri M, Herold U, Lange R, Krane M. Life Expectancy of Survivors of Type A Aortic Dissection: A Comparison with the General Population Over a Period of 40 Years. Thorac Cardiovasc Surg 2019. [DOI: 10.1055/s-0039-1678944] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- J. Boehm
- Technische Universität München, Deutsches Herzzentrum München, Klinik für Herzchirurgie, München, Germany
| | - M. Burri
- Technische Universität München, Deutsches Herzzentrum München, Klinik für Herzchirurgie, München, Germany
| | - U. Herold
- Technische Universität München, Deutsches Herzzentrum München, Klinik für Herzchirurgie, München, Germany
| | - R. Lange
- Technische Universität München, Deutsches Herzzentrum München, Klinik für Herzchirurgie, München, Germany
| | - M. Krane
- Technische Universität München, Deutsches Herzzentrum München, Klinik für Herzchirurgie, München, Germany
| |
Collapse
|
26
|
Krane M, Boehm J, Prinzing A, Lange R. Excellent Hemodynamic Results in Patients Undergoing the Ozaki Procedure for Aortic Valve Reconstruction within the First Year. Thorac Cardiovasc Surg 2019. [DOI: 10.1055/s-0039-1678893] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- M. Krane
- Technische Universität München, Klinik für Herzchirurgie, Deutsches Herzzentrum München, München, Germany
- DZHK, German Center for Cardiovascular Research, Munich, Germany
| | - J. Boehm
- Technische Universität München, Klinik für Herzchirurgie, Deutsches Herzzentrum München, München, Germany
| | - A. Prinzing
- Technische Universität München, Klinik für Herzchirurgie, Deutsches Herzzentrum München, München, Germany
| | - R. Lange
- Technische Universität München, Klinik für Herzchirurgie, Deutsches Herzzentrum München, München, Germany
- DZHK, German Center for Cardiovascular Research, Munich, Germany
| |
Collapse
|
27
|
My I, Laue S, Dressen M, Schmidt F, Brade T, Dorn T, Goedel A, Lahm H, Lickert H, Krane M, Moretti A, Laugwitz KL. P1848Primary cilium-autophagy-cell cycle axis defects impair cardiac progenitor specification in hypoplastic left heart syndrome. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p1848] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- I My
- Hospital Rechts der Isar, Molecular Cardiology, first department of medicine, TU, Munich, Germany
| | - S Laue
- Hospital Rechts der Isar, Molecular Cardiology, first department of medicine, TU, Munich, Germany
| | - M Dressen
- Deutsches Herzzentrum Technische Universitat, Department of cardiovascular surgery, division of experimental surgery, Munich, Germany
| | - F Schmidt
- Helmholtz Center Munich - German Research Center for Environment and Health, Institute of diabetes and regeneration research, Munich, Germany
| | - T Brade
- Hospital Rechts der Isar, Molecular Cardiology, first department of medicine, TU, Munich, Germany
| | - T Dorn
- Hospital Rechts der Isar, Molecular Cardiology, first department of medicine, TU, Munich, Germany
| | - A Goedel
- Hospital Rechts der Isar, Molecular Cardiology, first department of medicine, TU, Munich, Germany
| | - H Lahm
- Deutsches Herzzentrum Technische Universitat, Department of cardiovascular surgery, division of experimental surgery, Munich, Germany
| | - H Lickert
- Helmholtz Center Munich - German Research Center for Environment and Health, Institute of diabetes and regeneration research, Munich, Germany
| | - M Krane
- Deutsches Herzzentrum Technische Universitat, Department of cardiovascular surgery, division of experimental surgery, Munich, Germany
| | - A Moretti
- Hospital Rechts der Isar, Molecular Cardiology, first department of medicine, TU, Munich, Germany
| | - K.-L Laugwitz
- Hospital Rechts der Isar, Molecular Cardiology, first department of medicine, TU, Munich, Germany
| |
Collapse
|
28
|
Zhang Z, Mannhardt I, Dressen M, Neb I, Doppler S, Deutsch MA, Lahm H, Lange R, Hansen A, Krane M. 5331Functional analysis of induced pluripotent stem cell-derived cardiomyocytes from patients with hypoplastic left heart syndrome in engineered heart tissues. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.5331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Z Zhang
- German Heart Center of Munich, Adult and Paediatric Cardiovascular Surgery, Munich, Germany
| | - I Mannhardt
- University Medical Center Hamburg Eppendorf, Institut für Experimentelle Pharmakologie und Toxikologie, Hamburg, Germany
| | - M Dressen
- German Heart Center of Munich, Adult and Paediatric Cardiovascular Surgery, Munich, Germany
| | - I Neb
- German Heart Center of Munich, Adult and Paediatric Cardiovascular Surgery, Munich, Germany
| | - S Doppler
- German Heart Center of Munich, Adult and Paediatric Cardiovascular Surgery, Munich, Germany
| | - M.-A Deutsch
- German Heart Center of Munich, Adult and Paediatric Cardiovascular Surgery, Munich, Germany
| | - H Lahm
- German Heart Center of Munich, Adult and Paediatric Cardiovascular Surgery, Munich, Germany
| | - R Lange
- German Heart Center of Munich, Adult and Paediatric Cardiovascular Surgery, Munich, Germany
| | - A Hansen
- University Medical Center Hamburg Eppendorf, Institut für Experimentelle Pharmakologie und Toxikologie, Hamburg, Germany
| | - M Krane
- German Heart Center of Munich, Adult and Paediatric Cardiovascular Surgery, Munich, Germany
| |
Collapse
|
29
|
Dzilic E, Chirikian O, Shieh A, Ribeiro A, Goodyer RG, Serpooshan V, Li G, Kumar A, Dressen M, Lahm H, Doppler S, Lange R, Krane M, Wu S. P6220MYL2 reporter line allows purification of ventricular human iPSC induced cardiomyocytes. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p6220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- E Dzilic
- INSURE (Institute for Translational Cardiac Surgery), Department of Cardiovascular Surgery, German Heart Centre, TUM, Munich, Germany
| | - O Chirikian
- School of Medicine, Stanford Cardiovascular Institute, Stanford, United States of America
| | - A Shieh
- School of Medicine, Stanford Cardiovascular Institute, Stanford, United States of America
| | - A Ribeiro
- Stanford University, Department of Mechanical Engineering, Stanford, United States of America
| | - R G Goodyer
- School of Medicine, Stanford Cardiovascular Institute, Stanford, United States of America
| | - V Serpooshan
- School of Medicine, Stanford Cardiovascular Institute, Stanford, United States of America
| | - G Li
- School of Medicine, Stanford Cardiovascular Institute, Stanford, United States of America
| | - A Kumar
- School of Medicine, Stanford Cardiovascular Institute, Stanford, United States of America
| | - M Dressen
- INSURE (Institute for Translational Cardiac Surgery), Department of Cardiovascular Surgery, German Heart Centre, TUM, Munich, Germany
| | - H Lahm
- INSURE (Institute for Translational Cardiac Surgery), Department of Cardiovascular Surgery, German Heart Centre, TUM, Munich, Germany
| | - S Doppler
- INSURE (Institute for Translational Cardiac Surgery), Department of Cardiovascular Surgery, German Heart Centre, TUM, Munich, Germany
| | - R Lange
- INSURE (Institute for Translational Cardiac Surgery), Department of Cardiovascular Surgery, German Heart Centre, TUM, Munich, Germany
| | - M Krane
- INSURE (Institute for Translational Cardiac Surgery), Department of Cardiovascular Surgery, German Heart Centre, TUM, Munich, Germany
| | - S Wu
- School of Medicine, Stanford Cardiovascular Institute, Stanford, United States of America
| |
Collapse
|
30
|
Hoelscher S, Doppler S, Stich T, Kistner A, Lahm H, Dreßen M, Lange R, Hassel D, Krane M. miR-128: Pleiotropic Player in Cardiac Development. Thorac Cardiovasc Surg 2018. [DOI: 10.1055/s-0038-1628041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- S. Hoelscher
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technische Universität München, Munich, Germany
| | - S. Doppler
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technische Universität München, Munich, Germany
| | - T. Stich
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technische Universität München, Munich, Germany
| | - A. Kistner
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technische Universität München, Munich, Germany
| | - H. Lahm
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technische Universität München, Munich, Germany
| | - M. Dreßen
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technische Universität München, Munich, Germany
| | - R. Lange
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technische Universität München, Munich, Germany
| | - D. Hassel
- Department of Medicine III, Cardiology, Angiology, Pneumology, University Hospital Heidelberg, Heidelberg, Germany and DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, Heidelberg, Germany
| | - M. Krane
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technische Universität München, Munich, Germany
| |
Collapse
|
31
|
Nöbauer C, Böhm J, Günther T, Krane M, Lange R. Repair or Replacement for Isolated Tricuspid Valve Endocarditis? Thorac Cardiovasc Surg 2018. [DOI: 10.1055/s-0038-1627919] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- C. Nöbauer
- Herzchirurgie, Deutsches Herzzentrum München, München, Germany
| | - J. Böhm
- Herzchirurgie, Deutsches Herzzentrum München, München, Germany
| | - T. Günther
- Herzchirurgie, Deutsches Herzzentrum München, München, Germany
| | - M. Krane
- Herzchirurgie, Deutsches Herzzentrum München, München, Germany
| | - R. Lange
- Herzchirurgie, Deutsches Herzzentrum München, München, Germany
| |
Collapse
|
32
|
Krane M, Prinzing A, Nöbauer C, Boehm J, Lange R. Autologous Pericardium for Trileaflet Aortic Valve Reconstruction Reveals Excellent Early Hemodynamic Results. Thorac Cardiovasc Surg 2018. [DOI: 10.1055/s-0038-1627893] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- M. Krane
- Department of Cardiovascular Surgery, German Heart Center Munich, Munich, Germany
| | - A. Prinzing
- Department of Cardiovascular Surgery, German Heart Center Munich, Munich, Germany
| | - C. Nöbauer
- Department of Cardiovascular Surgery, German Heart Center Munich, Munich, Germany
| | - J. Boehm
- Department of Cardiovascular Surgery, German Heart Center Munich, Munich, Germany
| | - R. Lange
- Department of Cardiovascular Surgery, German Heart Center Munich, Munich, Germany
| |
Collapse
|
33
|
Boehm J, Krane M, Herold U, Wiesner G, Lange R. Serum Lactate Predicts Early Outcome and Long-term Survival after Aortic Type A Dissection: A Single-Center Experience over 16 Years. Thorac Cardiovasc Surg 2018. [DOI: 10.1055/s-0038-1628055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- J. Boehm
- Klinik für Herzchirurgie, Deutsches Herzzentrum München, Technische Universität München, München, Germany
| | - M. Krane
- Klinik für Herzchirurgie, Deutsches Herzzentrum München, Technische Universität München, München, Germany
| | - U. Herold
- Klinik für Herzchirurgie, Deutsches Herzzentrum München, Technische Universität München, München, Germany
| | - G. Wiesner
- Institut für Anästhesie, Deutsches Herzzentrum München, Technische Universität München, München, Germany
| | - R. Lange
- Klinik für Herzchirurgie, Deutsches Herzzentrum München, Technische Universität München, München, Germany
| |
Collapse
|
34
|
Boehm J, Krane M, Lange R. Changes in Perioperative Creatinine Levels Predict Long-term Survival after Cardiac Surgery with Cardiopulmonary Bypass: A Single-Center Analysis in 18072 Patients. Thorac Cardiovasc Surg 2018. [DOI: 10.1055/s-0038-1627976] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- J. Boehm
- Klinik für Herzchirurgie, Deutsches Herzzentrum München, Technische Universität München, München, Germany
| | - M. Krane
- Klinik für Herzchirurgie, Deutsches Herzzentrum München, Technische Universität München, München, Germany
| | - R. Lange
- Klinik für Herzchirurgie, Deutsches Herzzentrum München, Technische Universität München, München, Germany
| |
Collapse
|
35
|
Lahm H, Jia M, Dreßen M, Puluca N, Beck N, Cleuziou J, Doppler S, Deutsch M, Lichtner P, Eckstein G, Lange R, Meitinger T, Müller-Myhsok B, Krane M. GWAS Analysis Reveals Previously Unknown Genomic Variants Associated with Different Subgroups of Congenital Heart Disease. Thorac Cardiovasc Surg 2018. [DOI: 10.1055/s-0038-1628044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- H. Lahm
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - M. Jia
- Max-Planck Institute of Psychiatry, Munich, Germany
| | - M. Dreßen
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - N. Puluca
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - N. Beck
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - J. Cleuziou
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - S. Doppler
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - M. Deutsch
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - P. Lichtner
- Helmholtz-Center Munich, Institute of Human Genetics, Neuherberg, Germany
| | - G. Eckstein
- Helmholtz-Center Munich, Institute of Human Genetics, Neuherberg, Germany
| | - R. Lange
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - T. Meitinger
- Helmholtz-Center Munich, Institute of Human Genetics, Neuherberg, Germany
| | | | - M. Krane
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| |
Collapse
|
36
|
Dreßen M, Northoff B, Laue S, Neb I, Zhang Z, Gödel A, Doppler S, Deutsch M, Lahm H, Teupser D, Moretti A, Laugwitz KL, Holdt L, Lange R, Krane M. Identification of Differentially Regulated Pathways in Cardiac Development and Cardiac Gene Expression during In Vitro Cardiac Differentiation of HLHS-derived Human Induced Pluripotent Stem Cells using Transcriptome Analysis. Thorac Cardiovasc Surg 2018. [DOI: 10.1055/s-0038-1628043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- M. Dreßen
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - B. Northoff
- Institute for Laboratory Medicine, University Hospital, Ludwig-Maximilian University Munich, Munich, Germany
| | - S. Laue
- First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
| | - I. Neb
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - Z. Zhang
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - A. Gödel
- First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
| | - S. Doppler
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - M. Deutsch
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - H. Lahm
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - D. Teupser
- Institute for Laboratory Medicine, University Hospital, Ludwig-Maximilian University Munich, Munich, Germany
| | - A. Moretti
- First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
| | - K.-L. Laugwitz
- First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
| | - L. Holdt
- Institute for Laboratory Medicine, University Hospital, Ludwig-Maximilian University Munich, Munich, Germany
| | - R. Lange
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - M. Krane
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| |
Collapse
|
37
|
Krane M, Doll S, Dreßen M, Geyer P, Itzhak D, Braun C, Doppler S, Meyer F, Deutsch M, Lahm H, Lange R, Mann M. Region and Cell-type Specific Proteomic Map of the Human Heart. Thorac Cardiovasc Surg 2018. [DOI: 10.1055/s-0038-1628040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- M. Krane
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - S. Doll
- Proteomics and Signal Transduction, Max-Planck Institute of Biochemistry, Martinsried, Germany
| | - M. Dreßen
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - P. Geyer
- Proteomics and Signal Transduction, Max-Planck Institute of Biochemistry, Martinsried, Germany
| | - D. Itzhak
- Proteomics and Signal Transduction, Max-Planck Institute of Biochemistry, Martinsried, Germany
| | - C. Braun
- Department of Forensic Medicine, Ludwig Maximilian University Munich, Munich, Germany
| | - S. Doppler
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - F. Meyer
- Proteomics and Signal Transduction, Max-Planck Institute of Biochemistry, Martinsried, Germany
| | - M. Deutsch
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - H. Lahm
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - R. Lange
- Department of Cardiovascular Surgery, German Heart Center Munich at the Technical University of Munich, Munich, Germany
| | - M. Mann
- Proteomics and Signal Transduction, Max-Planck Institute of Biochemistry, Martinsried, Germany
| |
Collapse
|
38
|
Eichhorn S, Mendoza Garcia A, Polski M, Spindler J, Stroh A, Heller M, Lange R, Krane M. Corpuls cpr resuscitation device generates superior emulated flows and pressures than LUCAS II in a mechanical thorax model. Australas Phys Eng Sci Med 2017; 40:441-447. [PMID: 28258484 DOI: 10.1007/s13246-017-0537-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/23/2016] [Accepted: 02/11/2017] [Indexed: 11/24/2022]
Abstract
The provision of sufficient chest compression is among the most important factors influencing patient survival during cardiopulmonary resuscitation (CPR). One approach to optimize the quality of chest compressions is to use mechanical-resuscitation devices. The aim of this study was to compare a new device for chest compression (corpuls cpr) with an established device (LUCAS II). We used a mechanical thorax model consisting of a chest with variable stiffness and an integrated heart chamber which generated blood flow dependent on the compression depth and waveform. The method of blood-flow generation could be changed between direct cardiac-compression mode and thoracic-pump mode. Different chest-stiffness settings and compression modes were tested to generate various blood-flow profiles. Additionally, an endurance test at high stiffness was performed to measure overall performance and compression consistency. Both resuscitation machines were able to compress the model thorax with a frequency of 100/min and a depth of 5 cm, independent of the chosen chest stiffness. Both devices passed the endurance test without difficulty. The corpuls cpr device was able to generate about 10-40% more blood flow than the LUCAS II device, depending on the model settings. In most scenarios, the corpuls cpr device also generated a higher blood pressure than the LUCAS II. The peak compression forces during CPR were about 30% higher using the corpuls cpr device than with the LUCAS II. In this study, the corpuls cpr device had improved blood flow and pressure outcomes than the LUCAS II device. Further examination in an animal model is required to prove the findings of this preliminary study.
Collapse
Affiliation(s)
- S Eichhorn
- Department of Cardiovascular Surgery, Division of Experimental Surgery, German Heart Center Munich, Munich Heart Alliance, Lazarettstrasse 36, 80636, Munich, Germany.
| | - A Mendoza Garcia
- Fakultät für Informatik, Robotics and Embedded Systems, Technische Universität München, Munich, Germany
| | - M Polski
- Department of Cardiovascular Surgery, Division of Experimental Surgery, German Heart Center Munich, Munich Heart Alliance, Lazarettstrasse 36, 80636, Munich, Germany
| | - J Spindler
- Department of Cardiovascular Surgery, Division of Experimental Surgery, German Heart Center Munich, Munich Heart Alliance, Lazarettstrasse 36, 80636, Munich, Germany
| | - A Stroh
- Department of Cardiovascular Surgery, Division of Experimental Surgery, German Heart Center Munich, Munich Heart Alliance, Lazarettstrasse 36, 80636, Munich, Germany
| | - M Heller
- GS Elektromedizinische Geräte G. Stemple GmbH, Kaufering, Germany
| | - R Lange
- Department of Cardiovascular Surgery, Division of Experimental Surgery, German Heart Center Munich, Munich Heart Alliance, Lazarettstrasse 36, 80636, Munich, Germany.,DZHK (German Center for Cardiovascular Research) - Partner Site Munich Heart Alliance, Munich, Germany
| | - M Krane
- Department of Cardiovascular Surgery, Division of Experimental Surgery, German Heart Center Munich, Munich Heart Alliance, Lazarettstrasse 36, 80636, Munich, Germany.,DZHK (German Center for Cardiovascular Research) - Partner Site Munich Heart Alliance, Munich, Germany
| |
Collapse
|
39
|
Puluca N, Doppler S, Lahm H, Zhang Z, Dreßen M, Deutsch M, Lange R, Krane M. Cardiosphere-Derived Cells: A Possible Source for Regenerative Cell Therapy in Congenital Heart Diseases. Thorac Cardiovasc Surg 2017. [DOI: 10.1055/s-0037-1598857] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- N. Puluca
- Department of Cardiovascular Surgery, German Heart Center Munich, Clinic at the Technical University, München, Germany
| | - S. Doppler
- Department of Cardiovascular Surgery, German Heart Center Munich, Clinic at the Technical University, München, Germany
| | - H. Lahm
- Department of Cardiovascular Surgery, German Heart Center Munich, Clinic at the Technical University, München, Germany
| | - Z. Zhang
- Department of Cardiovascular Surgery, German Heart Center Munich, Clinic at the Technical University, München, Germany
| | - M. Dreßen
- Department of Cardiovascular Surgery, German Heart Center Munich, Clinic at the Technical University, München, Germany
| | - M.A. Deutsch
- Department of Cardiovascular Surgery, German Heart Center Munich, Clinic at the Technical University, München, Germany
| | - R. Lange
- Department of Cardiovascular Surgery, German Heart Center Munich, Clinic at the Technical University, München, Germany
| | - M. Krane
- Department of Cardiovascular Surgery, German Heart Center Munich, Clinic at the Technical University, München, Germany
| |
Collapse
|
40
|
Deutsch M, Erlebach M, Witt O, Burri M, Ziegelmüller J, Goppel G, Mazzitelli D, Krane M, Lange R, Bleiziffer S. Long-Term Outcome of High-Risk Patients Having Undergone TAVI with First-Generation Devices. Thorac Cardiovasc Surg 2017. [DOI: 10.1055/s-0037-1598749] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- M.A. Deutsch
- Department of Cardiovascular Surgery, German Heart Center Munich, Technical University of Munich, Munich, Germany
| | - M. Erlebach
- Department of Cardiovascular Surgery, German Heart Center Munich, Technical University of Munich, Munich, Germany
| | - O.G. Witt
- Department of Cardiovascular Surgery, German Heart Center Munich, Technical University of Munich, Munich, Germany
| | - M. Burri
- Department of Cardiovascular Surgery, German Heart Center Munich, Technical University of Munich, Munich, Germany
| | - J.A. Ziegelmüller
- Department of Cardiovascular Surgery, German Heart Center Munich, Technical University of Munich, Munich, Germany
| | - G. Goppel
- Department of Cardiovascular Surgery, German Heart Center Munich, Technical University of Munich, Munich, Germany
| | - D. Mazzitelli
- Department of Cardiovascular Surgery, German Heart Center Munich, Technical University of Munich, Munich, Germany
| | - M. Krane
- Department of Cardiovascular Surgery, German Heart Center Munich, Technical University of Munich, Munich, Germany
| | - R. Lange
- Department of Cardiovascular Surgery, German Heart Center Munich, Technical University of Munich, Munich, Germany
| | - S. Bleiziffer
- Department of Cardiovascular Surgery, German Heart Center Munich, Technical University of Munich, Munich, Germany
| |
Collapse
|
41
|
Lahm H, Doppler S, Deutsch MA, Jerrentrup C, Eckardt D, Wild S, Decker T, Lange R, Krane M. Modified RNA: An Efficient and Safe Approach for Gene Delivery In Vitro and In Vivo. Thorac Cardiovasc Surg 2016. [DOI: 10.1055/s-0036-1571556] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
42
|
Dreßen M, Lahm H, Adamzcyk-Wolf K, Cleuziou J, Kasnar-Samprec J, Schön P, Doppler S, Deutsch MA, Lange R, Krane M. Genetic Variants of TBX5 in Holt-Oram Syndrome Patients. Thorac Cardiovasc Surg 2016. [DOI: 10.1055/s-0036-1571512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
43
|
Deutsch MA, Doppler S, Li X, Ratschiller T, Lahm H, Jerrentrup C, Schiemann M, Santamaria G, Dreßen M, Wu S, Lange R, Krane M. Recurrence of an Embryonic Nkx2.5 Enhancer Positive Cardiac Cell Population after Myocardial Infarction in the Adult Mouse Heart: A Cell Source for Cardiac Regeneration? Thorac Cardiovasc Surg 2016. [DOI: 10.1055/s-0036-1571558] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
44
|
Deutsch MA, Doppler S, Lahm H, Dressen M, Lange R, Krane M. Endogene myokardiale Regeneration. Z Herz- Thorax- Gefäßchir 2015. [DOI: 10.1007/s00398-014-1119-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
45
|
Lahm H, Doppler S, Dreßen M, Adacmzyk K, Werner A, Deutsch MA, Schiemann M, Lange R, Krane M. Identification of Cardiac Progenitor Cells of the Second Heart Field by Application of ISLET1-Specific Fluorescent Reporter Probes Across Species Borders. Thorac Cardiovasc Surg 2015. [DOI: 10.1055/s-0035-1544336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
46
|
Dreßen M, Crotti L, Lahm H, Moretti A, Wolf K, Cleuziou J, Schön P, Hörer J, Schreiber C, Doppler S, Werner A, Deutsch MA, Schiemann M, Brade T, Laue S, Oexle K, Mastantuono E, Gruber P, Laugwitz KL, Meitinger T, Lange R, Krane M. Differential Expression of Candidate Genes with de novo Mutations in Patients with Hypoplastic Left Heart Syndrome in Murine Cardiac Progenitor Cells. Thorac Cardiovasc Surg 2015. [DOI: 10.1055/s-0035-1544380] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
47
|
Doppler S, Lahm H, Dreßen M, Deutsch MA, Schiemann M, Schunkert H, Erdmann J, Lange R, Krane M. MicroRNA Profile of Nkx2.5 Enhancer Positive Cardiac Progenitor Cells. Thorac Cardiovasc Surg 2015. [DOI: 10.1055/s-0035-1544332] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
48
|
Beckmann A, Lange R, Neumann T, Krane M, Welz A, Hamm C, Mohr F. 298 * QUALITY OF LIFE IN 9985 PATIENTS FOLLOWING AORTIC VALVE REPLACEMENT: ONE-YEAR RESULTS FROM THE GERMAN AORTIC VALVE REGISTRY. Interact Cardiovasc Thorac Surg 2014. [DOI: 10.1093/icvts/ivu276.298] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
49
|
Lange R, Beckmann A, Neumann T, Krane M, Zahn R, Cremer JT, Hamm C, Mohr F. 149 * QUALITY OF LIFE IN 3875 PATIENTS AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION: ONE-YEAR DATA FROM THE GERMAN AORTIC VALVE REGISTRY. Interact Cardiovasc Thorac Surg 2014. [DOI: 10.1093/icvts/ivu276.149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
50
|
Elhmidi Y, Bleiziffer S, Piazza N, Voss B, Krane M, Deutsch MA, Lange R. Long-term results after transcatheter aortic valve implantation: what do we know today? Curr Cardiol Rev 2014; 9:295-8. [PMID: 24313645 PMCID: PMC3941092 DOI: 10.2174/1573403x09666131202124227] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/03/2012] [Revised: 08/20/2012] [Accepted: 09/28/2012] [Indexed: 01/11/2023] Open
Abstract
Transcatheter aortic valve implantation (TAVI) is evolving rapidly as a therapeutic option in patients deemed to be at high risk for surgical aortic valve replacement. Early outcome and survival of controlled feasibility trials and single- center experience with TAVI have been previously reported. Valve performance and hemodynamics seem to improve significantly after TAVI. Long-term outcome up to 3 years have been demonstrated in recent studies. Admittedly, the results are encouraging with a survival rate at 2 and 3 years ranging from 62 to 74% and from 56 to 61% respectively. The improvement in hemodynamical and clinical status sustained beyond the 3 years follows up. However, paravalvular leakage after TAVI remains an important issue in this rapidely evolving field.
Collapse
Affiliation(s)
| | | | | | | | | | | | - R Lange
- German Heart Centre Munich, Lazarettestrasse 36, 80636, Munich, Germany.
| |
Collapse
|